Alkermes (ALKS) EPS (Basic) Growth (1y) (2011 - 2025)
Alkermes (ALKS) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -99.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,328.36% |
| Dec 31, 2024 | 102.75% |
| Sep 30, 2024 | 98.92% |
| Jun 30, 2024 | 90.81% |
| Mar 31, 2024 | 93.23% |
| Dec 31, 2023 | -145.83% |
| Sep 30, 2023 | 30.11% |
| Jun 30, 2023 | -37.57% |
| Mar 31, 2023 | -0.12% |
| Dec 31, 2022 | -31.19% |
| Sep 30, 2022 | -116.89% |
| Jun 30, 2022 | -1,351.28% |
| Mar 31, 2022 | -57.34% |
| Dec 31, 2021 | 390.27% |
| Sep 30, 2021 | -21,212.07% |
| Jun 30, 2021 | 107.94% |
| Mar 31, 2021 | 42.56% |
| Dec 31, 2020 | -323.82% |
| Sep 30, 2020 | 99.75% |
| Jun 30, 2020 | 30.75% |